US 12,231,559 B2
Neural network classifiers for block chain data structures
Victor Bovee Dods, Orinda, CA (US); Benjamin James Taylor, Las Vegas, NV (US); and Leonid Alekseyev, San Francisco, CA (US)
Assigned to LedgerDomain Inc., Las Vegas, NV (US)
Filed by LedgerDomain Inc., Las Vegas, NV (US)
Filed on Aug. 16, 2023, as Appl. No. 18/234,809.
Application 18/234,809 is a continuation of application No. 17/100,772, filed on Nov. 20, 2020, granted, now 11,764,959.
Application 17/100,772 is a continuation of application No. 16/740,348, filed on Jan. 10, 2020, granted, now 10,873,456, issued on Dec. 22, 2020.
Claims priority of provisional application 62/844,691, filed on May 7, 2019.
Prior Publication US 2024/0163097 A1, May 16, 2024
Int. Cl. H04L 29/06 (2006.01); G06N 3/08 (2023.01); G06N 5/025 (2023.01); G06N 20/00 (2019.01); H04L 9/14 (2006.01)
CPC H04L 9/14 (2013.01) [G06N 3/08 (2013.01); G06N 5/025 (2013.01); G06N 20/00 (2019.01)] 17 Claims
OG exemplary drawing
 
1. A method of securing information associated with a clinical trial, the method including:
storing, to block-level clinical trial structures of a blockchain, an on-chain record origin of clinical trial information received from a first custodian, wherein the on-chain record origin of the clinical trial information is an encrypted version of an original record of the clinical trial information signed with credentials of the first custodian;
receiving, from a first user seeking to validate a veracity of a first off-chain copy of the clinical trial information, a request to view the on-chain record of clinical trial information, from the block-level clinical trial structures stored to the blockchain;
permitting the first user to access the on-chain record of the clinical trial information in dependence upon an authorization;
receiving, from the first user, a validation of the veracity of the first off-chain copy of the clinical trial information as being unaltered from the on-chain record origin, wherein the validation further includes (i) an encrypted version of the first off-chain copy and (ii) credentials of the first user; and
storing, to the blockchain, the validation of the veracity of the first off-chain copy of the clinical trial information.